# A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.

> **NCT00549055** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 38 (actual)

## Conditions studied

- Neovascular Age-related Macular Degeneration

## Interventions

- **DRUG:** Macugen

## Key facts

- **NCT ID:** NCT00549055
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2018-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00549055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00549055, "A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00549055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*